Jeffrey S. Conrad
Geen lopende functies
Profiel
Mr. Jeffrey S.
Conrad is Secretary & Director at Abviva, Inc. and Partner at eFund Capital Management LLC.
He is on the Board of Directors at Abviva, Inc.
Mr. Conrad also served on the board at Probe Manufacturing, Inc.
He received his undergraduate degree from the University of California, Berkeley and a graduate degree from Loyola Law School.
Eerdere bekende functies van Jeffrey S. Conrad
| Bedrijven | Functie | Einde |
|---|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Directeur/Bestuurslid | 27-07-2009 |
eFund Capital Management LLC
 eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Corporate Officer/Principal | - |
Abviva, Inc.
 Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Directeur/Bestuurslid | - |
Opleiding van Jeffrey S. Conrad
| University of California, Berkeley | Undergraduate Degree |
| Loyola Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLEAN ENERGY TECHNOLOGIES, INC. | Producer Manufacturing |
| Bedrijven in privébezit | 2 |
|---|---|
Abviva, Inc.
Abviva, Inc. Medical SpecialtiesHealth Technology Abviva, Inc. develops and commercializes diagnostic and therapeutic products from Mammastatin, a growth-regulatory protein that inhibits breast cancer cell growth. The Mammastatin is normally present in the blood serum of healthy women and absent in women with breast cancer. The company develops breast cancer therapies through internal and external collaborative research with pharmaceutical, biotechnology and leading research institution world wide to commercialize the Mammastatin serum. It was founded on September 19, 1994 and is headquartered in Santa Barbara, CA. | Health Technology |
eFund Capital Management LLC
eFund Capital Management LLC Investment ManagersFinance eFund Capital Management LLC operated as a private equity fund. The company was headquartered in Long Beach, CA. | Finance |
